426 Bibliografia ù1] Beeckman D, Van Damme N, Schoonhoven L, et al. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016;11(11):CD011627. Published 2016 Nov 10. doi:10.1002/14651858. CD011627.pub2 [2] Banharak S, Panpanit L, Subindee S, et al. Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review. J Multidiscip Healthc. 2021;14:29833004. Published 2021 Oct 26. doi:10.2147/JMDH.S329672 [3] Beeckman D, Schoonhoven L, Verhaeghe S, Heyneman A, Defloor T. Prevention and treatment of incontinence-associated dermatitis: literature review. J Adv Nurs. 2009;65(6):1141-1154. doi:10.1111/j.1365-2648.2009.04986.x [4] Beeckman D, Woodward S, Gray M. Incontinence-associated dermatitis: step-by-step prevention and treatment. Br J Community Nurs. 2011;16(8):382-389. doi:10.12968/bjcn.2011.16.8.382 [5] Gray M, Bliss DZ, Doughty DB, Ermer-Seltun J, Kennedy-Evans KL, Palmer MH. Incontinence-associated dermatitis: a consensus. J Wound Ostomy Continence Nurs. 2007;34(1):45-56. doi:10.1097/00152192-200701000-00008 [6] McNichol LL, Ayello EA, Phearman LA, Pezzella PA, Culver EA. Incontinence-Associated Dermatitis: State of the Science and Knowledge Translation. Adv Skin Wound Care. 2018;31(11):502513. doi:10.1097/01.ASW.0000546234.12260.61 [7] Gray M, Giuliano KK. Incontinence-Associated Dermatitis, Characteristics and Relationship to Pressure Injury: A Multisite Epidemiologic Analysis. J Wound Ostomy Continence Nurs. 2018;45(1):63-67. doi:10.1097/WON.0000000000000390 [8] Berke CT. Incontinence-Associated Dermatitis (IAD). J Wound Ostomy Continence Nurs. 2016;43(5):453. doi:10.1097/ WON.0000000000000264 [9] Nesher L, Rolston KV. Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy. Clin Infect Dis. 2013;56(5):711-717. doi:10.1093/cid/cis998. [10] van Burik JA, Lawatsch EJ, DeFor TE, Weisdorf DJ. Cytomegalovirus enteritis among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant. 2001;7(12):674-679. doi:10.1053/bbmt.2001.v7.pm11787530. [11] Deeg HJ. How I treat refractory acute GVHD. Blood. 2007;109(10):4119-4126. doi:10.1182/blood-2006-12-041889. [12] Robak K, Zambonelli J, Bilinski J, Basak GW. Diarrhea after allogeneic stem cell transplantation: beyond graft-versushost disease. Eur J Gastroenterol Hepatol. 2017;29(5):495-502. doi:10.1097/MEG.0000000000000833. [13] Gray M, Giuliano KK. Incontinence-Associated Dermatitis, Characteristics and Relationship to Pressure Injury: A Multisite Epidemiologic Analysis. J Wound Ostomy Continence Nurs. 2018;45(1):63-67. doi:10.1097/WON.0000000000000390. [14] Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol. 2012;18(16):1851-1860. doi:10.3748/wjg.v18.i16.1851. [15] Liakopoulou E, Mutton K, Carrington D, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant. 2005;36(8):691-694. doi:10.1038/sj.bmt.1705127. [16] Kambham N, Higgins JP, Sundram U, Troxell ML. Hematopoietic stem cell transplantation: graft versus host disease and pathology of gastrointestinal tract, liver, and lung. Adv Anat Pathol. 2014;21(5):301-320. doi:10.1097/PAP.0000000000000032. [17] Weber S, Scheich S, Magh A, et al. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation. Int J Infect Dis. 2020;99:428436. doi:10.1016/j.ijid.2020.08.030. [18] Willems L, Porcher R, Lafaurie M, et al. Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2012;18(8):1295-1301. doi:10.1016/j.bbmt.2012.02.010. [19] Robak K, Zambonelli J, Bilinski J, Basak GW. Diarrhea after allogeneic stem cell transplantation: beyond graft-versushost disease. Eur J Gastroenterol Hepatol. 2017;29(5):495-502. doi:10.1097/MEG.0000000000000833 [20] del Campo L, León NG, Palacios DC, Lagana C, Tagarro D. Abdominal complications following hematopoietic stem cell transplantation. Radiographics. 2014;34(2):396-412. doi:10.1148/ rg.342135046. [21] Beeckman D, Van den Bussche K, Alves P, et al. The Ghent Global IAD Categorisation Tool (GLOBIAD). Skin Integrity Research Group - Ghent University 2017. Available to download from www.UCVVGent.be. [22] Voegeli D, Hillery S. Prevention and management of moisture-associated skin damage. Br J Nurs. 2021;30(15):S40-S46. doi:10.12968/bjon.2021.30.15.S40. [23] Cunich M, Barakat-Johnson M, Lai M, et al. The costs, health outcomes and cost-effectiveness of interventions for the prevention and treatment of incontinence-associated dermatitis: A systematic review. Int J Nurs Stud. 2022;129:104216. doi:10.1016/j. ijnurstu.2022.104216. [24] Humbert P, Dréno B, Krutmann J, et al. Recommendations for managing cutaneous disorders associated with advancing age. Clin Interv Aging. 2016;11:141-148. Published 2016 Feb 12. doi:10.2147/CIA.S96232. [25] Campbell JL, Coyer FM, Osborne SR. Incontinence-associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting. Int Wound J. 2016;13(3):403-411. doi:10.1111/iwj.12322. [26] Ousey K, O’Connor L, Doughty D, Hill R, Woo K. Incontinence-associated dermatitis Made Easy. London: Wounds International 2017; 8(2). Available from: www.woundsinternational.com. [27] Brazzelli M, Shirran E, Vale L. Absorbent products for containing urinary and/or fecal incontinence in adults. J Wound Ostomy Continence Nurs. 2002;29(1):45-54. doi:10.1067/mjw.2002.120870. [28] Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M; Medical Research Council Guidance. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj. a1655. PMID: 18824488; PMCID: PMC2769032. [29] Long MA, Reed LA, Dunning K, Ying J. Incontinence-associated dermatitis in a long-term acute care facility. J Wound Ostomy Continence Nurs. 2012;39(3):318-327. doi:10.1097/WON. 0b013e3182486fd7. [30] Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA; Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol. 2010;31(4):319-326. doi:10.1086/651091. [31] Meddings J, Saint S, Fowler KE, et al. The Ann Arbor Criteria for Appropriate Urinary Catheter Use in Hospitalized Medical Patients: Results Obtained by Using the RAND/UCLA Appropriateness Method. Ann Intern Med. 2015;162(9 Suppl):S1-S34. doi:10.7326/M14-1304.
RkJQdWJsaXNoZXIy ODUzNzk5